Phase III Trial of Dapivirine Ring Begins in Africa: ASPIRE testing new HIV prevention approach for women

Reduced Glycerin Formulation of Tenofovir Vaginal Gel Safe for Rectal Use

New findings reported by Microbicide Trials Network at International HIV Prevention Meeting

Rectal Formulation of Tenofovir Gel Found Safe and Acceptable in Early Phase Clinical Study

MTN Statement on Decision to Discontinue Use of Tenofovir Gel in VOICE, a Major HIV Prevention Study in Women

First Combination ARV Vaginal Ring for HIV Prevention Being Tested in Phase I Safety Trial

MTN Statement on Decision to Discontinue Use of Oral Tenofovir Tablets in VOICE, a Major HIV Prevention Study in Women

VOICE Study will Continue as it Considers What Action to Take After Results of Two Trials

Researchers Take Another Step Closer to HIV Prevention Product for Use During Pregnancy

HIV Prevention Trial Milestone: VOICE Study Completes Enrollment of 5,000 Women